PRADER-WILLI SYNDROME
Prader-Willi Syndrome (PWS) is a congenital syndrome that affects many systems of the body. Common early signs of PWS include muscle weakness, feeding difficulties, and behavioral disturbances. Patients may also experience excessive daytime sleepiness (EDS), making it difficult to perform everyday activities and negatively affecting their mood. The purpose of this study is to evaluate the efficacy and safety of the study medication on daytime sleepiness in those with Prader-Willi Syndrome.
STUDY: Evaluate the efficacy and safety of the study medication on daytime sleepiness in those with Prader-Willi Syndrome (PWS).
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for sleep disturbances in individuals with Prader-Willi Syndrome. If you are interested and available, please contact us today.
-
Length of trial: up to 1 year
-
Age range: 2 - 65 years of age
-
Treatment: The effectiveness and safety of an oral investigational drug that affects sleep in individuals with Autism Spectrum Disorder.
All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.
Narcolepsy Type 1 & Type 2
Narcolepsy is a chronic sleep disorder that causes excessive daytime sleepiness and difficulty staying awake during the day. People with narcolepsy may experience sudden sleep attacks, disrupted nighttime sleep, and difficulty maintaining a regular sleep-wake cycle.
Narcolepsy Type 1 may also include cataplexy, or sudden episodes of muscle weakness triggered by emotions such as laughter, excitement, or surprise. Narcolepsy Type 2 has similar symptoms but does not include cataplexy. Both types can affect daily activities, work, school, and overall quality of life.
STUDY: EVALUATE THE EFFECTIVENESS OF AN INVESTIGATIONAL DRUG ON NARCOLEPSY TYPE 1 & TYPE 2.
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for narcolepsy type 1 and 2. If you are interested and available, and you meet the qualifications outlined below, please contact us today.
-
Length of trial: 5-8 weeks, with an option to participate in an additional 11 months extension phase
-
Age range: 16-65 years of age
-
Treatment: The effectiveness and safety of an oral investigational drug that affects narcolepsy type 1 and 2.
Check Eligibility: https://smclinicaltrials.clinicalconductor.com/CCSWEB/Forms/frmuserwebdeployment.aspx?w=800
All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.
WHAT TO EXPECT
A clinical trial is scientific research designed to test if a medication or medical device is effective and well-tolerated for use by people.
PRE-SCREEN
First, a phone conversation is performed between the study volunteer and a member of the research staff to determine if the volunteer would be a good fit for the study.
SCREENING VISIT
Following pre-screen eligibility, the study volunteer visits the clinic to learn the details of the study that are outlined in the Informed Consent Form and begins participation in the study.
RANDOMIZATION VISIT
After successfully enrolling in the study, the study volunteer is randomized into a study treatment group either consisting of placebo or the investigational product.
STUDY VISITS
Every study has its own established number of clinic visits, phone call visits, and/or at-home visits which are performed throughout the duration of the study. These visits may include lab draws, questionnaires, or exams depending on the study protocol.
POST-TREATMENT FOLLOW UP
After successful completion of the clinical trial, the study volunteer will either visit the clinic or have a phone call visit to record any changes in the participant's health.